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Abstract
Aneurysms of the petrous segment of the internal carotid artery (ICA) are exceedingly rare.
They are thought to arise from traumatic, mycotic, or congenital etiologies. We present a case of
bilateral giant fusiform aneurysms of the petrocavernous ICA treated with bilateral flow-
diverting stent placement.
An 18-year-old male presented to our institution with headaches, nausea, vomiting and blurry
vision that had been present since the day prior. Visual exam revealed decreased visual acuity
bilaterally and a temporal field cut superiorly and inferiorly of the left eye. CT and MR imaging
revealed bilateral lesions of the petrous segment of the ICA bilaterally. Catheter angiography
demonstrated bilateral giant fusiform aneurysm of the petrocavernous ICA. The patient was
treated with aspirin 325 mg and clopidogrel 75 mg orally daily for one week prior to the exam.
VerifyNow (Accriva; San Diego, CA) confirmed adequate platelet inhibition. The right ICA was
treated first, with a multiple flow-diverting stent construct. No complications were noted and
the patient was discharged to home two days later. He was brought back three weeks later, and
the left ICA was treated with a multiple flow-diverting stent construct. Again, no complications
were noted and the patient was discharged uneventfully. The patient returned for his six-month
follow-up angiogram with improvement of his visual acuity and resolution of headaches.
However, the patient had ceased taking both anti-platelet medications six weeks prior.
Angiography revealed no filling of the aneurysm in the right ICA, however, the left ICA was
occluded at the origin. The patient was resumed on daily aspirin 325 mg orally and will have
follow-up catheter angiography at 12 months.
Petrous segment ICA aneurysms are rare. Most are thought to arise from trauma, infection, or
congenital etiologies. These aneurysms are typically fusiform in nature, and can extend into the
cavernous segment of the ICA. The natural history of these aneurysms is not well understood
given their rarity. Current literature advocates for asymptomatic patients to be treated
conservatively given that the natural history is not well known. Treatment is recommended in
symptomatic patients, who may present with symptoms of local mass effect or ischemic stroke
due to emboli. Endovascular options include flow diverting stent or covered stent placement,
coil embolization with or without stent-assistance, or ICA occlusion. Open surgical options
include trapping and high-flow bypass.
When bilateral lesions are present, the management algorithm must be amended. We elected to
treat the asymptomatic side first (right ICA), due to the presence of a significant kink within the
aneurysm on the left. Once the right side was treated successfully, the symptomatic side was
treated with a multiple stent construct.




Report  DOI: 10.7759/cureus.8662
How to cite this article
Mantripragada K, Echeverry N, Mansour S, et al. (June 17, 2020) Treatment of Bilateral Giant Fusiform
Petrocavernous Aneurysms. Cureus 12(6): e8662. DOI 10.7759/cureus.8662
The patient’s six-month angiogram demonstrated occlusion of the left ICA, likely due to non-
compliance with antiplatelet medications. This further reiterates the need for dual-antiplatelet
therapy and patient education and compliance with flow diverting stents.
We report a rare case of bilateral giant fusiform petrocavernous aneurysms treated with
bilateral Pipeline embolization devices in multiple device construct, demonstrating the
feasibility and safety of this treatment option for this pathology.
Categories: Neurology, Neurosurgery
Keywords: petrocavernous aneurysm, treatment of petrocavernous aneurysm, bilateral giant fusiform
aneurysm
Introduction
Aneurysms of the petrous segment of the internal carotid artery (ICA) are exceedingly rare [1,2].
Treatment of aneurysms within the petrous ICA is further complicated by the architecture of
this portion of the carotid artery. The petrous segment begins where the ICA penetrates the
temporal bone at a 90-degree angle from which it initially ascends vertically (vertical segment,
~10 mm) until turning anteromedially (genu segment) to become the horizontal segment where
it continues for ~20 mm towards the petrous apex, finally ending at the foramen lacerum
[3]. Aneurysms that form within this segment of the ICA are enclosed by the temporal bone and
thus more difficult to treat than those within other segments of the ICA that are not enclosed
within the skull base [4].
These aneurysms can be further subclassified into true aneurysms and pseudoaneurysms of the
petrous ICA. True aneurysms are thought to arise from trauma. Pseudoaneurysms do not have a
true wall and arise when a thrombus and fibrous tissue capsule develops possibly secondary to
blunt or penetrating trauma, infections, inflammation, or radiation. Other possible causes of
aneurysm development include mycotic origins or congenital etiologies. Aneurysm
development from mycotic origins is likely secondary to an adventitial infection, such as
chronic otomastoiditis, tonsillar and pharyngeal infections, and even cholesteatomas
[1]. Aneurysm development from congenital origins likely arises from developmental defects in
the muscular middle layer of the vessel.
We present a case of bilateral giant fusiform aneurysms of the petrocavernous ICA treated with
bilateral flow-diverting stent placement. Aneurysms of the petrous segment of the ICA are rare,
and bilateral giant fusiform aneurysms are exceedingly rare.
Case Presentation
An 18-year-old male presented to our institution with headaches, nausea, vomiting and blurry
vision that had been present since the day prior. Visual exam revealed decreased visual acuity
bilaterally and a temporal field cut superiorly and inferiorly of the left eye.
CT and MRI revealed bilateral giant fusiform aneurysms of the petrous portion of the internal
carotid artery (Figure 1), which was confirmed with catheter cerebral angiography (Figure 2).
2020 Mantripragada et al. Cureus 12(6): e8662. DOI 10.7759/cureus.8662 2 of 6
FIGURE 1: CT transverse (A), MRI transverse (B), and MRI
coronal (C) revealed bilateral lesions of the petrous segment of
the internal carotid artery (ICA) bilaterally
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FIGURE 2: Catheter angiography demonstrated bilateral giant
fusiform aneurysm of the petrocavernous internal carotid
artery (ICA)
The patient was started on aspirin 325 mg and clopidogrel 75 mg to achieve adequate platelet
inhibition. VerifyNow (Accriva; San Diego, CA) confirmed adequate platelet inhibition.
The left ICA aneurysm had a significant kink that would present a challenge for reconstruction
with flow diversion. If the left ICA were not able to be reconstructed successfully and
subsequently occluded, the patient would have depended on the diseased right ICA for
supplying both hemispheres. Thus, the right ICA aneurysm, though asymptomatic, was treated
first to ensure adequate treatment prior to treatment of the left ICA. The right ICA aneurysm
was treated using a multiple-flow diverting stent construct with the Pipeline Embolization
Device (Medtronic, Irvine, CA), followed by the left ICA aneurysm three weeks later. He was
brought back three weeks later, and the left ICA was treated with a multiple flow-diverting
stent construct.
After each individual treatment, there were no complications noted, and the patient was
discharged. The patient returned for his six-month follow-up angiogram with improvement of
his visual acuity and resolution of headaches. However, the patient had ceased taking both
anti-platelet medications six weeks prior. Angiography revealed no filling of the aneurysm in
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the right ICA, however, the left ICA was occluded at the origin. The patient was resumed on
daily aspirin 325 mg orally and will have follow-up catheter angiography in six months.
Discussion
Despite being considered intracranial aneurysms, petrous aneurysms in asymptomatic patients
are managed conservatively because they are extradural [1,2]. Patients with asymptomatic
extradural ICA aneurysms are typically managed with long-term observation and management
of controllable risk factors such as high blood pressure and tobacco use [4-6].
Depending on their size and location, some petrous aneurysm may cause symptoms including
headaches, tinnitus, hearing loss, visual changes, or other symptoms resulting from mass effect
[1,4,7]. For those patients with either symptomatic presentation or documented growth,
neurosurgical intervention is recommended [2]. If the patient is asymptomatic, watchful
observation is encouraged given the limited data regarding the natural history of these lesions.
Interventions typically utilized in the treatment of unruptured intracranial aneurysms include
ICA occlusion (with or without high flow external carotid to internal carotid bypass), aneurysm
embolization, and flow diverting stent placement [5]. The Pipeline embolization device was
utilized because it provides permanent aneurysm occlusion without temporary or permanent
occlusion of the parent vessel [8,9].
In the presented case, we utilized the Pipeline embolization device, a type of flow diverting
stent. The Pipeline embolization device is a self-expanding endoluminal mesh tube which
diverts blood flow within the ICA past the site of aneurysm, allowing for uninterrupted blood
flow while simultaneously leading to thrombosis of the target aneurysm [10]. Within the past
decade, flow diverters have become a commonly utilized intervention in the management of
intracranial aneurysms [9]. Flow diverting stents offer several advantages over traditional
interventions including complete and permanent aneurysm occlusion as well as providing
scaffolding over which a neointimal layer can grow at the diseased portion of the ICA [9].
Additionally, for certain aneurysms, they provide decreased risk of procedural complications
which are more commonly seen in open aneurysmal clipping while also reducing the aneurysm
recurrence seen in endovascular coiling [8,9].
Conclusions
Petrous aneurysms are already uncommon; bilateral petrous aneurysms are even more so, thus
there is no defined treatment algorithm for the management of these lesions. Given the
patient's left temporal hemianopsia as well as the increased complexity of the left ICA anatomy,
the right-sided aneurysm was treated with the flow diversion first to preserve arterial supply to
both hemispheres in the event the left ICA could not be reconstructed successfully. At the six-
month follow-up, the patient reported non-compliance with antiplatelet medications and
angiography showed occlusion of the left ICA. In spite of this, the right ICA demonstrated
normal flow with no filling of the right ICA aneurysm. Given that no procedural complications
were noted and the asymptomatic left ICA occlusion was likely due to medication
noncompliance, we can conclude that this treatment option is both safe and efficacious in the
management of bilateral petrous aneurysms.
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